John J.

John J. is a seasoned professional in the life sciences sector with extensive experience in business development, finance, and leadership roles. Currently serving as Co-Founder and CFO/CBO at D3 Bio since January 2021, John previously worked as a Founding Partner at Hanne Capital, focusing on cross-border investments in biotech and medtech sectors in China and the US/EU. Prior roles include advisory positions in business development and financing, and leadership positions at BeiGene and TaiGen Biotechnology, where John oversaw global business development efforts and significant licensing transactions. With a solid educational background including an MBA from The Wharton School, a Ph.D. in Immunology from Cornell University, and an MD from Peking University, John brings a unique combination of scientific expertise and business acumen to the industry.